By Admin at 7 Nov 2016
A genetic test known as the 21-gene recurrence score assay (RS) measures the activity of genes that control cell growth and more. A high score on the test indicates a woman has a high risk of cancer recurrence and chemotherapy is recommended. A low score suggests chemotherapy can safely be skipped.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial